Journal of Clinical Nuclear Medicine Publishes Results of Tiziana’s Nasal Foralumab in Study Treating Moderate Alzheimer's DiseaseNEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd.

The global market for pharmacovigilance is forecasted to attain USD 9,000.0 million by 2025, expanding at 8.8% CAGR to reach USD 20,902.9 million by 2035. In 2024, the revenue of pharmacovigilance was ...

As GDPR marks its seventh anniversary, new data from SurveyMonkey, the world's most popular platform for surveys and forms, highlights how UK businesses continue to grapple with data protection ...

Siyata Mobile Inc.  ("Siyata" or the "Company"), a global developer and vendor of mission-critical Push-to-Talk over Cellular (PoC) handsets and accessories, today announced that Core Gaming, a rising ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Bankrupt genetic testing company 23andMe has been sold to Regeneron Pharmaceuticals for $256 million. The deal includes ...

A grantee of the Gates Foundation, Hong Kong-based Phase Scientific built a business on the back of Covid-19 tests. Up next: ...

"I've got a pretty wild story to tell you," the early YouTube star Caspar Lee says in a TikTok. He goes on to tell the story ...

Codexis Inc. (NASDAQ:CDXS), active in the biotechnology space, has seen a rise in institutional participation. The company’s trajectory and segment focus reflect broader activity patterns across the ...

Equity markets worldwide receded in the first quarter, as the outlooks for corporate spending and global economic growth were ...